Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma
Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
Interventions
- BIOLOGICAL: CMV pp65 peptide
- BIOLOGICAL: hTERT I540/R572Y/D988Y multipeptide vaccine
- BIOLOGICAL: pneumococcal polyvalent vaccine
- BIOLOGICAL: survivin Sur1M2 peptide vaccine
Sponsor
University of Maryland Greenebaum Cancer Center
Collaborators